Forbion Capital Partners Founded 2006
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 51
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 51
Rounds per year 3.40
Lead investments 22
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Areas of investment
Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
Therapeutics
Summary

Forbion Capital Partners is the famous VC, which was founded in 2007. The company was established in Europe in The Netherlands. The leading representative office of defined VC is situated in the Naarden.

The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline AM Pharma, Mitralign, BioVex Among the most popular fund investment industries, there are Clinical Trials, Health Diagnostics. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Forbion Capital Partners, startups are often financed by Oxford Bioscience Partners, Giza Venture Capital, ABN AMRO Fund. The meaningful sponsors for the fund in investment in the same round are Oxford Bioscience Partners, New Science Ventures, Andera Partners. In the next rounds fund is usually obtained by Takeda Ventures, Oxford Bioscience Partners, NGN Capital.

The higher amount of exits for fund were in 2015. Speaking about the real fund results, this VC is 14 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. Opposing the other organizations, this Forbion Capital Partners works on 10 percentage points more the average amount of lead investments. The average startup value when the investment from Forbion Capital Partners is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2011. Despite it in 2019 the fund had an activity.

Besides them, we counted 10 critical employees of this fund in our database.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
PanGenetics
Pharmaceutical
Series C
23M05 Mar 2008 Netherlands, Utrecht
Dyne Therapeutics
Biotechnology
Health Care
Medical
Pharmaceutical
Series A
50M03 Apr 2019 United Kingdom, Cambridge
Acorda Therapeutics
Biotechnology
Developer Platform
Health Care
Series B
55M20 May 2003 United States, Mount Pleasant
arGEN-X
Biotechnology
Clinical Trials
Therapeutics
Series A
4M11 Feb 2010 Netherlands, Rotterdam
arGEN-X
Biotechnology
Clinical Trials
Therapeutics
Series B
32M01 Dec 2011 Netherlands, Rotterdam
Pulmologix
Clinical Trials
Health Care
Medical
Venture - Series Unknown
9M18 Sep 2014 Sweden, Stockholm
Replimune Group
Biotechnology
Health Care
Medical
Therapeutics
Seed
2M08 May 2015 United States, Woburn
NorthSea Therapeutics
Biotechnology
Health Care
Therapeutics
Series B
36M08 Jan 2020 Netherlands, Naarden
Curetis
Biotechnology
Genetics
Health Diagnostics
Medical
Series A
11M26 Oct 2011 Germany, Holzgerlingen
Bluebird Bio
Biotechnology
Genetics
Health Diagnostics
Pharmaceutical
Series C
30M20 Apr 2011 United Kingdom, Cambridge
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Forbion Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: